Accelerating Drug Development with AI-Enabled 3D Spatial Biology

August 29, 2023 

    • Tags:

Alpenglow founder and CEO Nick Reder, M.D., discusses how Alpenglow’s platform combines the company’s unique imaging technology with cloud-based AI analysis software to transform pathology to better meet the needs of drug developers and accelerate drug discovery.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: